Patents Examined by Kade Ariani
  • Patent number: 11612163
    Abstract: Methods for stabilizing blood samples, e.g., clinical blood samples, for storage or transportation before use.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: March 28, 2023
    Assignee: The General Hospital Corporation
    Inventors: Rebecca Sandlin, Keith Wong, Shannon Tessier, Mehmet Toner, Shannon Stott
  • Patent number: 11612675
    Abstract: The invention is directed to a biological bandage derived from fish skin (e.g. tilapia skin) that can be used with healing of wounds such as burn wounds. The edible property of the fish skin biological bandage according to various embodiments makes it suitable for both human and veterinary medicine.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: March 28, 2023
    Assignee: The Regents of the University of California
    Inventor: Jamie Peyton
  • Patent number: 11596674
    Abstract: This invention provides, in part, various compositions and methods for protecting the gastrointestinal microbiome from antibiotic disruption.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: March 7, 2023
    Assignee: Synthetic Biologies, Inc.
    Inventors: Michael Kaleko, Sheila Connelly, Vincent John Wacher
  • Patent number: 11583534
    Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: February 21, 2023
    Assignee: Ortho-Nutra, LLC
    Inventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
  • Patent number: 11583563
    Abstract: Adeno-associated liquid and lyophilized pharmaceutical compositions are provided herein. In exemplary aspects, the pharmaceutical compositions comprise about 5 mM to about 25 mM L-histidine, about 0 mM to about 150 mM sodium chloride, about 0.001% (w/v) to about 0.01% (w/v) polysorbate 80 (PS80), and about 1% to about 10% (w/v) sucrose, trehalose, or combination thereof to AAV. In exemplary aspects, the pharmaceutical compositions further comprise glycine or mannitol. Methods of preparing a pharmaceutical composition comprising AAV, methods of treating a bleeding disorder in a subject, and methods of storing AAV compositions are also provided.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: February 21, 2023
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Christian Fiedler, Eva Fritscher, Meinhard Hasslacher, Dominik Mittergradnegger, Tanvir Tabish
  • Patent number: 11576936
    Abstract: A method of treating cancer includes administering a dose of a chemotherapy agent in combination with a dose of a composition consisting essentially of attenuated Salmonella typhimurium. The dose of the chemotherapy agent is lower than a maximum effective dose of the chemotherapy agent. The combination provides a synergistic reduction in tumor burden when compared to the reduction in tumor burden provided by administration of an equivalent dose of the chemotherapy agent without the composition consisting essentially of attenuated Salmonella typhimurium.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: February 14, 2023
    Assignee: Salspera, LLC
    Inventor: Daniel A. Saltzman
  • Patent number: 11554163
    Abstract: A method for prophylaxis and/or treatment of coagulopathy in a subject caused by a viral infection is provided. The method includes administering prourokinase or its variant; the viral infection is caused by a coronavirus.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: January 17, 2023
    Inventor: Jianning Liu
  • Patent number: 11530383
    Abstract: The present invention provides methods to improve the health and vigor, including enhancement of the growth of plants, including important crop plants. In particular, the present invention provides methods of treating or preventing a rhizogenic or tumorigenic plant disease caused by bacteria, comprising administering to the plant an effective amount of at least one isolated Paenibacillus strain or of an extract of at least one isolated Paenibacillus strain, wherein said at least one Paenibacillus strain comprises a 16S rRNA sequence with at least 93% sequence identity to the sequence of SEQ ID NO: 1.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: December 20, 2022
    Assignees: KATHOLIEKE UNIVERSITEIT LEUVEN, NEDERLANDS INSTITUTE OF ECOLOGY (NIOO-KNAW), SCIENTIA TERRAE VZW, PROEFSTATION GROENTETEELT, PROEFCENTRUM HOOGSTRATEN
    Inventors: Lien Bosmans, Bart Lievens, Hans Rediers, Jos Raaijmakers, Irene De Bruijn
  • Patent number: 11518976
    Abstract: An object of the present invention is to provide a method for efficiently obtaining a lactic acid bacterium that is made to contain a large amount of double-stranded RNA; and a lactic acid bacterium having a high double-stranded RNA content obtained by the method. The object is achieved by: (1) a method for producing a double-stranded RNA-containing lactic acid bacterium, including a step of culturing a lactic acid bacterium under at least one condition of an aeration condition and a low-temperature condition lower than an optimum temperature, thereby obtaining the double-stranded RNA-containing lactic acid bacterium; (2) a double-stranded RNA-containing lactic acid bacterium, in which the content of double-stranded RNA is 2.0 times or more as compared with the content of double-stranded RNA when a bacterium of the same strain is cultured for the same culture time under an optimum temperature and non-aeration condition; or the like.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: December 6, 2022
    Assignee: KIKKOMAN CORPORATION
    Inventors: Tadaomi Kawashima, Naho Ikari, Hiroshi Kawamoto
  • Patent number: 11517614
    Abstract: This invention provides, in part, various compositions and methods for protecting the gastrointestinal microbiome from antibiotic disruption from orally administered antibiotics.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: December 6, 2022
    Assignee: Synthetic Biologics, Inc.
    Inventors: Michael Kaleko, Sheila Connelly
  • Patent number: 11512338
    Abstract: A medium containing (A) a chromogenic substance which develops a color when decomposed by ?-glucosidase or a fluorogenic substance which develops a fluorescence when decomposed by ?-glucosidase; (B) a chromogenic substance which develops a color when decomposed by phosphatidyl inositol-specific phospholipase C or a fluorogenic substance which develops a fluorescence when decomposed by phosphatidyl inositol-specific phospholipase C; and (C) a sugar that is useful for the detection of Listeria monocytogenes and/or Listeria ivanovii.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: November 29, 2022
    Assignee: NISSUI PHARMACEUTICAL CO., LTD.
    Inventors: Shuhei Hosokawa, Shingo Mizuochi, Mitsuaki Kashida
  • Patent number: 11499174
    Abstract: The present invention relates to a method of producing glutathione, wherein photosynthetic membrane vesicles and enzymes catalyzing glutathione synthesis are combined and glutamate, cysteine and glycine are used as reaction substrates. As enzymes catalyzing glutathione synthesis, ?-glutamylcysteine synthetase and glutathione synthetase may be used together, or bifunctional glutathione synthetase may be used alone. According to the conventional methods, there is a problem in that expensive adenosine triphosphate should be continuously supplied when glutathione is produced. However, according to the present invention, since photosynthetic membrane vesicles are used as a source to regenerate adenosine triphosphate, it is possible to continuously produce glutathione without additionally adding adenosine triphosphate, thereby reducing production costs of glutathione.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: November 15, 2022
    Assignee: SOGANG UNIVERSITY RESEARCH FOUNDATION
    Inventors: Jeong Kug Lee, Hyeon Jun Kim, Eun Kyoung Oh
  • Patent number: 11486882
    Abstract: Use of a limited digestion with a proteolytic enzyme of a multispecific antibody for the analysis of the multispecific antibody's light chain pairing.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: November 1, 2022
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Michael Molhoj, Maximiliane Koenig, Vincent Larraillet, Katja Montan, Bianca Gruenwalder
  • Patent number: 11470864
    Abstract: The present invention relates to a culture or kit-of-part comprising a Lactobacillus delbrueckii subsp lactis strain, and uses thereof to manufacture a cereal-based lactic acid-fermented product, in particular a maize-based lactic acid-fermented product such as mahewu.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: October 18, 2022
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Pascal Fourcassie, Claire Bonard, Veronique Laffitte, Brett Wordon
  • Patent number: 11466266
    Abstract: The disclosure relates to methods for the screening, identification, and/or application of one or more microorganisms of use in imparting one or more beneficial properties to one or more plants.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: October 11, 2022
    Assignee: BIOCONSORTIA, INC.
    Inventors: Peter Wigley, Caroline George, Susan Turner
  • Patent number: 11452295
    Abstract: Planting corn in one or more consecutive growing seasons in the same fields causes a yield reduction (“corn-on-corn yield penalty”). We developed methods and inoculants comprising Penicillium bilaii, to reduce corn-on-corn yield penalty. The disclosure covers the inoculants and methods for reducing corn-on-corn yield penalty.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: September 27, 2022
    Assignee: Monsanto Technology LLC
    Inventors: Bradon James Fabbri, Ken Ferreira, Janne Kerovuo, Matthew McCown, Radha G. Mohanty, Scott R. Schaecher
  • Patent number: 11447803
    Abstract: Disclosed are techniques and systems for producing microbials having anaplerotic oils that are rich in odd-chain fatty acids, and other beneficial components, at higher concentrations than those present in other natural dietary sources of OCFA, at lower cost, and higher production yield. Such compositions can comprise pentadecanoic and heptadecanoic fatty acids. The techniques described herein include methods for producing and deriving such compositions rich in odd-chain fatty acids from microbials, including microalgae and yeasts/fungi.
    Type: Grant
    Filed: November 5, 2020
    Date of Patent: September 20, 2022
    Assignee: HELIAE DEVELOPMENT, LLC
    Inventors: Eneko Ganuza Taberna, Magdalena Amezquita Ernult, Charles Sellers
  • Patent number: 11446412
    Abstract: Compositions and methods of transplanting cells by grafting strategies into solid organs (especially internal organs) are provided. These methods and compositions can be used to repair diseased organs or to establish models of disease states in experimental hosts. The method involves attachment onto the surface of a tissue or organ, a patch graft, a “bandaid-like” covering, containing epithelial cells with supporting early lineage stage mesenchymal cells. The cells are incorporated into soft gel-forming biomaterials prepared under serum-free, defined conditions comprised of nutrients, lipids, vitamins, and regulatory signals that collectively support stemness of the donor cells. The graft is covered with a biodegradable, biocompatible, bioresorbable backing used to affix the graft to the target site. The cells in the graft migrate into and throughout the tissue such that within a couple of weeks they are uniformly dispersed within the recipient (host) tissue.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: September 20, 2022
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Lola M. Reid, Wencheng Zhang, Eliane Wauthier
  • Patent number: 11439151
    Abstract: An agricultural medium to control plant disease and nematodes by first applying to the agricultural medium an effective amount of an aqueous peroxyacetic acid composition; and then inoculating the soil with beneficial organisms.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: September 13, 2022
    Assignee: BioSafe Systems LLC
    Inventor: Robert Larose
  • Patent number: 11432551
    Abstract: The present invention provides methods for the cultivation of the Methylobacterium genus of bacteria. In particular the method provides methods for the efficient and inexpensive cultivation of these bacteria. Additionally, the invention provides methods for the utilization of these bacterial cultures to improve plant agriculture.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: September 6, 2022
    Assignee: NewLeaf Symbiotics, Inc.
    Inventor: Gregg Bogosian